Vibrio Diagnostics Market Share, Analysis, Trends To 2020 by Grand View ResVibrio diagnostics market

Vibrio Diagnostics Market Analysis By Technology (PCR, monoclonal immunoassays

antibodies, (EIA),

immunoprecipitation,

flow

cytometry, diagnostic

Fluorescent

enzyme imaging,

immunoassays

and

immune-PCR), By End-users (hospitals, Public Health Laboratories, Private diagnostic labs and commercial diagnostic labs) And Segment Forecasts To 2020

Advancement in the diagnostics techniques such as enzyme immunoassays (EIA) and polymerase chain reaction (PCR), increased healthcare expenditure, affordability of diagnostics devices and kits are the major drivers for the growth of vibrio diagnostics market. Global warming is expected to provide the favorable environment for the bacteria resulting into more of the diseases in human.

For More Information on "Vibrio Diagnostics Market Research Reports" visit

-

http://www.grandviewresearch.com/industry-analysis/vibrio-

diagnostics-market

Rising intake of uncooked and raw seafood, unhygienic living conditions and improper sanitation are the factors for the increasing cases of vibrio infections.

Cholera leads to shock, circulatory collapse, vomiting and profuse watery diarrhea.

If not treated on time approximately 50 percent of the cases can be fatal. Global organizations such as UNICEF, WHO and CDC are involved in reducing the cholera incidences by introducing regulations and policies such as improvement of drinking water quality and minimization of water pollution.

Polymerase chain reaction (PCR) is anticipated to witness rapid growth in technology segment owing to the advancement in technology coupled with increasing research and development in the developed nations such as the U.S and Canada. Hospitals are expected to dominate the vibrio diagnostics market during the forecast period due to the rise in awareness and improvement in the healthcare facilities. Cholera which is an acute illness based on diarrhea is caused by vibrio cholera and is expected to grow in the emerging economies of Asia Pacific such as China and India during the forecast period owing to the increasing pollution and population. V. parahaemolyticus that causes cholera is found in coastal waters of Canada and the U.S and the concentration increases during summer.

In humans it causes gastrointestinal illness and lives in brackish salt water.

Cholera though widely eliminated still is the main cause for the deaths in various African countries. The percentage of people dying from cholera remains highest in Africa due to the lack of access to basic healthcare facilities. Key players of the vibrio diagnostics market are Eiken Chemical Co. Ltd., Dickinson and Company, Abbott Laboratories, Novartis Diagnostics, Becton, F. Hoffmann-La Roche Ltd and DiamedixImpex S.A. Request TOC of “Vibrio Diagnostics Market Research Reports" visit http://www.grandviewresearch.com/industry-analysis/vibrio-diagnosticsmarket/request-toc

About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco.

The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact: Sherry James Corporate Sales Specialist, U.S.A. Grand View Research, Inc. United States

Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Website: Grand View Research Blog Site: http://marketshare.blog.com/